Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP)

CUSIP: 45339J105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
113,265,306
Total 13F shares
1,687,829
Share change
-147,820
Total reported value
$6,751,000
Price per share
$4.00
Number of holders
9
Value change
-$661,036
Number of buys
4
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) as of Q1 2022

As of 31 Mar 2022, Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,687,829 shares. The largest 9 holders included Stratos Wealth Partners, LTD., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, INVESTMENT HOUSE LLC, STATE STREET CORP, UNITED CAPITAL FINANCIAL ADVISERS, LLC, NORTHERN TRUST CORP, UBS Group AG, and NATIONAL BANK OF CANADA /FI/. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.